Ascendis Pharma
ASND
ASND
171 hedge funds and large institutions have $7.85B invested in Ascendis Pharma in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 67 increasing their positions, 50 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.3% less ownership
Funds ownership: 102.85% → 102.55% (-0.3%)
15% less capital invested
Capital invested by funds: $9.25B → $7.85B (-$1.39B)
21% less call options, than puts
Call options by funds: $9.62M | Put options by funds: $12.2M
Holders
171
Holding in Top 10
14
Calls
$9.62M
Puts
$12.2M
Top Buyers
| 1 | +$71.2M | |
| 2 | +$32.9M | |
| 3 | +$30.2M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$24.2M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$20.9M |
Top Sellers
| 1 | -$229M | |
| 2 | -$42.8M | |
| 3 | -$38.8M | |
| 4 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
-$29.2M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$16.1M |